Dr. Henry Fung and his Fox Chase colleagues present a Continuing Medical Education event on developments in Aggressive Lymphoma; Myelodysplasia; Plasma Cell Dyscrasia; Acute Leukemia and Myeloproliferative Disease; Less Common Lymphomas; Consultative Hemato...
Read MoreTrainee Spotlight: Rossella Tricarico, PhD
Rossella Tricarico, PhDPostdoctoral AssociateDr. Alfonso Bellacosa’s labFox Chase Cancer [email protected] I was an undergraduate student at the University of Bari in Italy, the molecular characterization of the Philadelphia chromosome w...
Read MoreTrainee Spotlight: Rossella Tricarico, PhD
Mayor Jim Kenney Attends BMT Outpatient Clinic Ribbon Cutting
On Thursday, February 11, 2016, Temple University Health System officials hosted a ribbon cutting for a brand new Fox Chase Cancer Center-Temple University Hospital Bone Marrow Transplant (BMT) Outpatient Clinic. Fox Chase President and CEO, Richard I. Fish...
Read MoreMayor Jim Kenney Attends BMT Outpatient Clinic Ribbon Cutting
Trainee Spotlight: Sanjeevani Arora, PhD
Sanjeevani Arora, PhD Postdoctoral Fellow Drs. Erica Golemis’, PhD, and Greg H. Enders’, MD, PhD, Labs Fox Chase Cancer Center [email protected] Biography I was drawn to biology and chemistry from very early on in life. My fa...
Read MoreTrainee Spotlight: Sanjeevani Arora, PhD
Ovarian Cancer Genetics: Many genes, many tests
From Prevention Matters Newsletter, Fall/Winter 2015 The National Comprehensive Cancer Network (NCCN) considers genetic testing of the BRCA1 and BRCA2 genes appropriate for any woman with a personal history of ovarian, fallopian tube, or primary peritoneal ...
Read MoreOvarian Cancer Genetics: Many genes, many tests
Post-transplantation Relapse in Lymphomas
If the lymphoma comes back (relapses) after having received a stem cell transplant, treatment options are very limited. Treatment of a post-transplant relapse is further complicated by residual side effects related to the transplant. In the world of bone...
Read MorePost-transplantation Relapse in Lymphomas
Share
-
Share with Facebook
-
Share with twitter
-
Share with email
-
Print this